Type 1 Diabetes — NZ Condition Guide | KiwiMeds

What is Type 1 Diabetes?

Type 1 diabetes is an autoimmune condition where the immune system destroys the insulin-producing beta cells in the pancreas, leaving the body unable to produce insulin. Without insulin, cells cannot absorb glucose from the blood for energy, causing dangerously high blood sugar levels. Type 1 diabetes affects around 20,000–25,000 New Zealanders and can develop at any age, though it most commonly begins in childhood, adolescence, or young adulthood. It is a lifelong condition requiring daily insulin therapy.

Symptoms

Type 1 diabetes often presents rapidly with the classic “4 Ts”: Thirst (excessive thirst and dry mouth), Toilet (frequent urination), Tired (fatigue and lethargy), and Thinner (unexplained weight loss). Other symptoms include fruity-smelling breath, blurred vision, and abdominal pain. Without treatment, diabetic ketoacidosis (DKA) — a life-threatening emergency — can develop rapidly. If you or your child has these symptoms, seek medical attention urgently.

Causes and Risk Factors

Type 1 diabetes is caused by autoimmune destruction of pancreatic beta cells — the immune system mistakenly attacks the body’s own insulin-producing cells. The exact trigger is unknown but involves a combination of genetic susceptibility and environmental factors (possibly viral infections). Unlike type 2 diabetes, type 1 is not caused by diet or lifestyle.

Diagnosis

Type 1 diabetes is diagnosed with blood tests showing elevated blood glucose levels (fasting glucose ≥7.0 mmol/L or random glucose ≥11.1 mmol/L with symptoms) and often HbA1c ≥50 mmol/mol. Autoantibody tests (e.g. GAD antibodies) can help confirm the autoimmune nature. C-peptide testing shows very low or absent insulin production.

Treatment in New Zealand

Type 1 diabetes requires lifelong insulin therapy — without insulin, survival is not possible. Insulin must be injected (subcutaneously) or delivered via an insulin pump. In NZ, all standard insulins are funded by Pharmac. Continuous glucose monitors (CGMs) — devices that continuously track blood sugar — are funded by Pharmac for all people with type 1 diabetes in NZ since 2022, which was a landmark decision. Insulin pumps are partially funded for eligible patients. Diabetes NZ and the Type 1 Foundation NZ provide excellent support.

NZ-Specific Information

New Zealand made history in 2022 when Pharmac funded continuous glucose monitors (CGMs) for all people with type 1 diabetes — one of the first countries to do so universally. This has significantly improved blood sugar management and quality of life. Free diabetes education and dietitian support is available through GPs and diabetes centres. School support plans are available for children with type 1 diabetes.

Frequently Asked Questions

Is type 1 diabetes the same as type 2? No — they are completely different conditions. Type 1 is autoimmune, requires insulin, and is not related to lifestyle. Type 2 is largely related to insulin resistance and lifestyle. Will my child outgrow type 1 diabetes? No — type 1 diabetes is lifelong. However, technology (CGMs, insulin pumps) has transformed management. Can type 1 diabetes be prevented? Not currently, though research into prevention strategies is ongoing.

Supplements That May Support Management

⚠️ Important: The supplements listed below have varying levels of clinical evidence. They are not a substitute for prescribed medications and should only be considered as adjunctive support under the guidance of a qualified healthcare professional. Always inform your GP or pharmacist before commencing any supplement, as interactions with prescribed medicines are possible.

• Vitamin D — People with type 1 diabetes have higher rates of vitamin D deficiency, which is associated with impaired insulin secretion and increased autoimmune activity. Supplementation is recommended where deficiency is confirmed by blood testing.
• Magnesium — Magnesium deficiency is common in type 1 diabetes, particularly in those with suboptimal glycaemic control. Deficiency impairs glucose transport and insulin signalling. Supplementation at 200–400 mg/day is appropriate where dietary intake is insufficient.
• Omega-3 Fatty Acids — Omega-3 supplementation supports cardiovascular protection, which is particularly important given the elevated cardiovascular risk in type 1 diabetes. EPA/DHA also modulate autoimmune inflammatory pathways.
• Alpha-Lipoic Acid (ALA) — ALA at 600–1200 mg/day has evidence for reducing symptoms of peripheral diabetic neuropathy, a complication that can develop even in well-managed type 1 diabetes. It supports antioxidant defence in peripheral nerves.
• Vitamin C and E (antioxidants) — Oxidative stress is elevated in type 1 diabetes and contributes to vascular complications. Antioxidant vitamins may provide complementary support when dietary intake is inadequate.

Relevant Vaccinations

Individuals living with type 1 diabetes may benefit from the following vaccinations. Please discuss your vaccination status with your GP or practice nurse, as eligibility and funding through the New Zealand National Immunisation Schedule may apply.

• Influenza (annual) — Type 1 diabetes significantly increases risk of influenza complications. Annual vaccination is funded and strongly recommended.
• Pneumococcal — Funded and recommended for people with type 1 diabetes. Diabetes reduces immune competence increasing susceptibility to pneumococcal disease.
• Hepatitis B — Recommended for those who have not been previously immunised, particularly given risk of transmission from shared glucose monitoring and insulin delivery equipment.
• COVID-19 — People with type 1 diabetes are at higher risk of severe COVID-19 and diabetic ketoacidosis triggered by acute illness. Maintaining up-to-date COVID-19 vaccination is strongly recommended.

Dietary Guidance

Evidence-based dietary modifications play a meaningful role in the management of type 1 diabetes. The following foods are generally recommended as part of a balanced, condition-appropriate diet. A referral to a registered dietitian may be beneficial for personalised nutritional planning.

• Consistent carbohydrate management (not elimination) — Carbohydrate counting and consistent intake is fundamental to type 1 diabetes management, enabling accurate insulin dosing. All carbohydrate sources affect blood glucose; distribution and consistency matter more than type.
• Low glycaemic index foods — Low-GI foods produce slower, more predictable glucose rises, reducing post-prandial insulin dosing complexity and glycaemic variability.
• Oily fish (cardiovascular protection) — People with type 1 diabetes have significantly elevated cardiovascular risk from an early age. Dietary omega-3 from fish supports vascular health.
• Fibre-rich vegetables and legumes — High fibre intake slows carbohydrate absorption, reducing post-prandial glucose excursions and supporting insulin sensitivity where residual beta-cell function exists.
• Limit: ultra-processed foods, sugar-sweetened beverages — These cause unpredictable glycaemic excursions and increase cardiovascular risk without nutritional benefit.

Related Conditions & Medications

Related medications: Insulin. Related conditions: Type 2 Diabetes.